Journal article icon

Journal article

Striant SR: a novel, effective and convenient testosterone therapy for male hypogonadism.

Abstract:

Striant SR (marketed as Striant in the US) is a novel sustained-release mucoadhesive buccal testosterone tablet for the treatment of male hypogonadism. Striant SR restores serum testosterone concentrations to the physiological range within 4 h of application, and steady-state concentrations are achieved within 24 h of twice-daily dosing. In phase III clinical trials, 87-97% of patients using Striant SR achieved 24-h-averaged serum testosterone concentrations within the normal range. In a comp...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Journal:
International journal of clinical practice
Volume:
58
Issue:
11
Pages:
1073-1080
Publication date:
2004-11-05
DOI:
EISSN:
1742-1241
ISSN:
1368-5031
URN:
uuid:bfe57dca-f48d-47d4-8c65-09a749dad9f4
Source identifiers:
138377
Local pid:
pubs:138377

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP